DNL628 clinical trials

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DNL628 in Participants With Early Alzheimer's Disease

This study is testing a new drug, DNL628, for people with early Alzheimer's disease. Researchers want to see if it's safe, how the body handles it, and if it has any effects. Participants will receive either the drug or a placebo.